| Dr Valerie D'aurora, MD | |
|
2815 S. Seacrest Blvd, Boynton Beach, FL 33435 | |
| (551) 208-6680 | |
| Not Available |
| Full Name | Dr Valerie D'aurora |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 14 Years |
| Location | 2815 S. Seacrest Blvd, Boynton Beach, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144560236 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 25MA10638600 (New Jersey) | Secondary |
| 2085R0204X | Radiology - Vascular & Interventional Radiology | ME129313 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jfk Medical Center | Atlantis, FL | Hospital |
| Palms West Hospital | Loxahatchee, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Physician Solutions Of Florida Llc | 3870716731 | 87 |
News Archive
"The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul," Kaiser Health News reports.
A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.
Harbor BioSciences, Inc. today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark Office which covers its lead metabolic disease and anti-inflammation drug candidate Triolex (HE3286). The patent claims cover compounds including Triolex and formulations that contain the drug or the other claimed compounds.
It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.
› Verified 9 days ago
| Entity Name | Radiology Associates Of South Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699759183 PECOS PAC ID: 5799689659 Enrollment ID: O20031121000573 |
News Archive
"The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul," Kaiser Health News reports.
A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.
Harbor BioSciences, Inc. today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark Office which covers its lead metabolic disease and anti-inflammation drug candidate Triolex (HE3286). The patent claims cover compounds including Triolex and formulations that contain the drug or the other claimed compounds.
It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.
› Verified 9 days ago
| Entity Name | Bethesda-ct Scan Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376588731 PECOS PAC ID: 4284521071 Enrollment ID: O20040304000725 |
News Archive
"The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul," Kaiser Health News reports.
A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.
Harbor BioSciences, Inc. today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark Office which covers its lead metabolic disease and anti-inflammation drug candidate Triolex (HE3286). The patent claims cover compounds including Triolex and formulations that contain the drug or the other claimed compounds.
It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.
› Verified 9 days ago
| Entity Name | Tower Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467654244 PECOS PAC ID: 2860470077 Enrollment ID: O20040713000446 |
News Archive
"The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul," Kaiser Health News reports.
A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.
Harbor BioSciences, Inc. today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark Office which covers its lead metabolic disease and anti-inflammation drug candidate Triolex (HE3286). The patent claims cover compounds including Triolex and formulations that contain the drug or the other claimed compounds.
It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.
› Verified 9 days ago
| Entity Name | Mori Bean And Brooks Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093782070 PECOS PAC ID: 8820077878 Enrollment ID: O20040714001317 |
News Archive
"The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul," Kaiser Health News reports.
A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.
Harbor BioSciences, Inc. today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark Office which covers its lead metabolic disease and anti-inflammation drug candidate Triolex (HE3286). The patent claims cover compounds including Triolex and formulations that contain the drug or the other claimed compounds.
It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.
› Verified 9 days ago
| Entity Name | Florida United Radiology Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407809395 PECOS PAC ID: 9537156757 Enrollment ID: O20080627000517 |
News Archive
"The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul," Kaiser Health News reports.
A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.
Harbor BioSciences, Inc. today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark Office which covers its lead metabolic disease and anti-inflammation drug candidate Triolex (HE3286). The patent claims cover compounds including Triolex and formulations that contain the drug or the other claimed compounds.
It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.
› Verified 9 days ago
| Entity Name | Radiology Physician Solutions Of Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356767651 PECOS PAC ID: 3870716731 Enrollment ID: O20140521001511 |
News Archive
"The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul," Kaiser Health News reports.
A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.
Harbor BioSciences, Inc. today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark Office which covers its lead metabolic disease and anti-inflammation drug candidate Triolex (HE3286). The patent claims cover compounds including Triolex and formulations that contain the drug or the other claimed compounds.
It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.
› Verified 9 days ago
| Entity Name | F&s Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518299957 PECOS PAC ID: 0244368868 Enrollment ID: O20140731002204 |
News Archive
"The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul," Kaiser Health News reports.
A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.
Harbor BioSciences, Inc. today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark Office which covers its lead metabolic disease and anti-inflammation drug candidate Triolex (HE3286). The patent claims cover compounds including Triolex and formulations that contain the drug or the other claimed compounds.
It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Valerie D'aurora, MD 2815 S. Seacrest Blvd, Boynton Beach, FL 33435 Ph: (561) 968-7968 | Dr Valerie D'aurora, MD 2815 S. Seacrest Blvd, Boynton Beach, FL 33435 Ph: (551) 208-6680 |
News Archive
"The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul," Kaiser Health News reports.
A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.
Harbor BioSciences, Inc. today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark Office which covers its lead metabolic disease and anti-inflammation drug candidate Triolex (HE3286). The patent claims cover compounds including Triolex and formulations that contain the drug or the other claimed compounds.
It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.
› Verified 9 days ago
Alfred Sem, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2815 S Seacrest Blvd, Attention: Betsy Cox, Boynton Beach, FL 33435 Phone: 561-736-1200 Fax: 561-742-1919 | |
Dr. David Dahlenburg, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2815 S Seacrest Blvd, Boynton Beach, FL 33435 Phone: 561-737-7733 | |
Carol Ann Vicinanza Adami, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2815 S Seacrest Blvd, Attention: Betsy Cox, Boynton Beach, FL 33435 Phone: 561-736-1200 Fax: 561-742-1919 | |
Fred Tow, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 8921 Raven Rock Ct, Boynton Beach, FL 33473 Phone: 941-356-2266 | |
Ariana Alvarez, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2815 S Seacrest Blvd, Attention Betsy Cox, Boynton Beach, FL 33435 Phone: 561-736-1200 Fax: 561-742-1919 | |
Richard Edelstein, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2815 S Seacrest Blvd, Attention: Betsy Cox, Boynton Beach, FL 33435 Phone: 561-736-1200 Fax: 561-742-1919 |